MWA Asset Management’s Vertex Pharmaceuticals VRTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $2.34M | Buy |
5,259
+334
| +7% | +$149K | 1.43% | 22 |
|
|
2025
Q1 | $2.39M | Buy |
4,925
+1,739
| +55% | +$843K | 1.66% | 18 |
|
|
2024
Q4 | $1.28M | Buy |
3,186
+603
| +23% | +$243K | 0.85% | 39 |
|
|
2024
Q3 | $1.2M | Sell |
2,583
-2,018
| -44% | -$939K | 0.8% | 43 |
|
|
2024
Q2 | $2.16M | Buy |
4,601
+2,491
| +118% | +$1.17M | 1.54% | 16 |
|
|
2024
Q1 | $882K | Sell |
2,110
-99
| -4% | -$41.4K | 0.64% | 54 |
|
|
2023
Q4 | $899K | Buy |
2,209
+1,011
| +84% | +$411K | 0.74% | 45 |
|
|
2023
Q3 | $417K | Buy |
+1,198
| New | +$417K | 0.4% | 76 |
|